MEN1 and gonorrhea: Similarly, the mutations involving the MEN1 oncosuppressor, linked to the homonymous syndrome, are associated with PAs in 15–50% of affected patients and a higher frequency of macroadenomas, that in 1/3 of cases are more invasive than non-MEN1 tumors (6).